Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: An updated systemic review and meta-analysis

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Wong, George K C ^a   Boet, Ronald ^b   Poon, Wai S ^a   Chan, Matthew T V ^a   Gin, Tony ^a   Ng, Stephanie C P ^a   Zee, Benny C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b St George's Hospital   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; MAGNESIUM; MAGNESIUM SULFATE; PLACEBO; NEUROPROTECTIVE AGENT;

ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; DELAYED CEREBRAL ISCHEMIA; DRUG EFFICACY; ELECTROLYTE BALANCE; EMBASE; GLASGOW OUTCOME SCALE; HUMAN; HYPOCALCEMIC TETANY; HYPOTENSION; INFORMATION RETRIEVAL; LIMB WEAKNESS; MAGNESIUM BLOOD LEVEL; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RISK ASSESSMENT; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TETANY; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

CEREBRAL INFARCTION; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 79551633705     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10017     Document Type: Article

References (30)

1. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997, 28:491-499.
2. Wong GK, Ng RY, Poon WS. Aneurysmal subarachnoid haemorrhage. Surgical Practice 2008, 12:51-55.
3. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50:1413-1418.
4. Boet R, Mee E. Magnesium sulphate in the management of patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000, 47:602-607. 10.1097/00006123-200009000-00014, 10981747.
5. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2002, 9:279-281. 10.1054/jocn.2001.1039, 12093134.
6. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD. Magnesium sulphate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002, 96:510-514. 10.3171/jns.2002.96.3.0510, 11883835.
7. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ. Magnesium therapy after aneurysmal subarachnoid haemorrhage: a dose-finding study for long term treatment. Acta Neurochir (Wien) 2003, 145:195-199. 10.1007/s00701-002-1064-9, 12632115.
8. van den Bergh WM, . on behalf of the MASH Study Group Magnesium sulphate in aneurysmal subarachnoid hemorrhage. Stroke 2005, 36:1011-1015. 10.1161/01.STR.0000160801.96998.57, 15790946, on behalf of the MASH Study Group.
9. Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulphate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 2006, 18:142-148. 10.1097/00008506-200604000-00009, 16628069.
10. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006, 58:1054-1065. 10.1227/01.NEU.0000215868.40441.D9, 16723884.
11. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulphate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008, 69:33-39. 10.1016/j.surneu.2007.07.015, 18054611.
12. Wong GK, Poon WS, Boet R, Chan MT, Gin T, Ng SC, Zee B, . IMASH investigators Intravenous magnesium sulphate after aneurysmal subarachnoid hemorrhage: a multi-center phase III study. Stroke 2010, 41:921-926. 10.1161/STROKEAHA.109.571125, 20378868, IMASH investigators.
13. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized placebo-controlled, clinical study. Crit Care Med 2010, 38:1284-1290. 10.1097/CCM.0b013e3181f17878, 20228677.
14. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:2315-2321. 10.1161/STROKEAHA.107.484360, 17569871.
15. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Drier JP, Roos YB. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observation studies: proposal of a multidisciplinary research group. Stroke 2010, 41:2391-2395. 10.1161/STROKEAHA.110.589275, 20798370.
16. Dorhout Mees SM, Rinkel GJ, Feign VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007, (3):CD000277.
17. Zhao XD, Zhou YT, Zhang X, Zhuang Z, Shi JX. A meta-analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neurosci 2009, 16:1394-1397. 10.1016/j.jocn.2009.05.001, 19700328.
18. Ma L, Lu WG, Zhang JM, Chen G, Fan J, Sheng HS. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Brain Injury 2010, 24:730-735. 10.3109/02699051003610516, 20334471.
19. Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and Extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 1998, 15:573-585. 10.1089/neu.1998.15.573, 9726257.
20. Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structural interview to assign grades on the modified Rankin Scale. Stroke 2002, 33:2243-2246. 10.1161/01.STR.0000027437.22450.BD, 12215594.
21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavanghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
22. Macedo SK, Nuss RM, Pereira S, Siqueira CM, Siquerira SB, Lima DP. Effect of magnesium on prophylaxis of vasospasm, morbidity, and mortality in subarachnoid hemorrhage patients. Critical Care 2009, 13:P54.
23. Prevedello DM, Cordeiro JG, de Morais AL, Saucedo NS, Chen IB, Araujo JC. Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surg Neurol 2006, 65 Suppl 1:S1:14-S1:20. 10.1016/j.surneu.2005.11.035, 16427437.
24. Keller E, Muroi C. Magnesium sulfate for subarachnoid hemorrhage: a piece of the mosaic. Stroke 2010, 41:e576. author reply e577, 10.1161/STROKEAHA.110.589903, 20724718.
25. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989, 298:636-642. 10.1136/bmj.298.6674.636, 2496789.
26. Higgins JP, Altman DG, . (editors) Assessing risk of bias in included studies. Cochrane Handbook for Systemic Reviews of Interventions 2008, Chichester (UK): John Wiley & Sons, Higgins JP, Green S, (editors).
27. Hopyan J, Ciarallo A, Dowlatshahi D, Howard P, John V, Yeung R, Zhang L, Kim J, MacFarlane G, Lee TY, Aviv RI. Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology 2010, 255:142-153. 10.1148/radiol.09091021, 20308452.
28. Wong GK, Poon WS, Boet R, Chan MT, Gin T, Ng SC, Zee B, . IMASH investigators Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post-hoc analysis of Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage (IMASH) Trial. Stroke 2010, 41:1841-1844. 10.1161/STROKEAHA.110.585232, 20538692, IMASH investigators.
29. Kreiter KT, Mayer SA, Howard G, Knappertz V, Ilodigwe D, Sloan MA, Macdonald RL. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke 2009, 40:2362-2367. 10.1161/STROKEAHA.109.547331, 19461029.
30. van den Bergh WM. Magnesium in subarachnoid haemorrhage: proven beneficial?. Magnes Res 2009, 22:121-126.